Company to host webcast today, December 1, 2025, at 4:30 p.m. Eastern time NORTH PLAINS, Ore., Dec. 01, 2025 (GLOBE NEWSWIRE) -- Jewett-Cameron Trading Company Ltd. (the “Company”; Nasdaq: JCTC), a company committed to innovative products that enrich outdoor spaces, today announced operational and financial results for the fiscal 2025 full year and fourth quarter for the period ended August 31, 2025. The Company has begun implementation of its strategic realignment to promote growth and profitability follow ...

Financial Performance & Guidance - Preliminary Q3 2023 surgical revenue is expected to be between $103.3 million and $103.9 million, representing a year-over-year (YoY) increase of 31% to 32%[4] - Preliminary Q3 2023 EOS revenue is expected to be between $14.3 million and $14.5 million, a YoY increase of 27% to 29%[4] - Total revenue for Q3 2023 is projected to be between $117.7 million and $118.5 million, reflecting a YoY growth of 31% to 32%[4] - Full-year 2023 surgical revenue guidance has been updated to $414 million, a 33% YoY increase[5] - Full-year 2023 EOS revenue guidance remains at $58 million, a 21% YoY increase[5] - Total revenue guidance for FY2023 has been increased by $10 million to $472 million, representing a 32% YoY increase[5] Strategic Focus & Innovation - ATEC is uniquely 100% spine focused, driving innovation from the operating room, not the board room[7, 9, 10] - ATEC aims to improve precision, predictability, and durability in spine surgery, addressing the 25-30% of surgeries that require revision[11, 12] - ATEC's innovation addresses the goals of spine surgery: decompression, stabilization, and alignment, strongly correlated to successful clinical outcomes[19, 25] - ATEC is positioning to capitalize on industry disruptions, adding 30 sales professionals from disrupted companies[32] Technology & Solutions - EOS imaging objectively answers essential clinical questions, providing full-body, standing, functional global alignment assessment with less radiation[52, 65] - The Catalyst system, expected to launch in 2024, will provide automated alignment reports, surgical planning, and patient-specific rods[68] - ATEC's lateral approach, including PTP (Prone Transpsoas) and LTP (Lateral Transpsoas), aims to address the hurdles of first-generation lateral surgery, with LTP designed for single-position surgery for L3 to S1[98, 122] - Valence, ATEC's navigation and robotics platform, is designed to be practical, economical, and ASC (Ambulatory Surgery Center) suitable[151]